Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study

Area of Science:

• Immunology
• Endocrinology
• Autoimmune Diseases

Background:

• Hashimoto's thyroiditis (HT) pathogenesis involves T-cell mediated immunity, but mechanisms remain unclear.
• Macrophage migration inhibitory factor (MIF) is implicated in various autoimmune conditions.
• Investigating serum MIF in HT can elucidate its role in thyroid autoimmunity.

Purpose of the Study:

• To assess serum MIF levels in Hashimoto's thyroiditis patients.
• To correlate MIF concentrations with thyroid hormone levels and autoantibodies.
• To explore the potential role of MIF in HT pathogenesis.

Main Methods:

• Serum samples from 93 untreated HT patients and 53 healthy controls were analyzed.
• Thyroid function tests (TSH, FT4, FT3) and autoantibodies (TGAb, TPOAb) were measured.
• Serum MIF levels were quantified using ELISA, and thyroid ultrasonography was performed.

Main Results:

• Serum MIF levels were significantly higher in patients with overt hypothyroidism compared to euthyroid patients with HT (p=0.036).
• MIF concentrations showed variations across different stages of thyroid dysfunction in HT patients.
• No correlation was explicitly stated with autoantibodies or FT4/FT3 in the provided results.

Conclusions:

• Macrophage migration inhibitory factor (MIF) levels increase in overt hypothyroidism associated with Hashimoto's thyroiditis.
• Further research is warranted to fully understand MIF's contribution to the pathogenesis of Hashimoto's thyroiditis.